BNXTF
Price
$0.67
Change
+$0.01 (+1.52%)
Updated
Sep 5 closing price
Capitalization
80.55M
SDZXF
Price
$62.16
Change
+$2.69 (+4.52%)
Updated
Aug 22 closing price
Capitalization
26.19B
55 days until earnings call
Interact to see
Advertisement

BNXTF vs SDZXF

Header iconBNXTF vs SDZXF Comparison
Open Charts BNXTF vs SDZXFBanner chart's image
BIONXT SOLUTIONS
Price$0.67
Change+$0.01 (+1.52%)
Volume$450
Capitalization80.55M
Sandoz Group AG
Price$62.16
Change+$2.69 (+4.52%)
Volume$316
Capitalization26.19B
BNXTF vs SDZXF Comparison Chart in %
Loading...
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SDZXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNXTF vs. SDZXF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNXTF is a Hold and SDZXF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BNXTF: $0.66 vs. SDZXF: $62.16)
Brand notoriety: BNXTF and SDZXF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BNXTF: 76% vs. SDZXF: 21%
Market capitalization -- BNXTF: $80.55M vs. SDZXF: $26.19B
BNXTF [@Pharmaceuticals: Generic] is valued at $80.55M. SDZXF’s [@Pharmaceuticals: Generic] market capitalization is $26.19B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNXTF’s FA Score shows that 0 FA rating(s) are green whileSDZXF’s FA Score has 0 green FA rating(s).

  • BNXTF’s FA Score: 0 green, 5 red.
  • SDZXF’s FA Score: 0 green, 5 red.
According to our system of comparison, SDZXF is a better buy in the long-term than BNXTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNXTF’s TA Score shows that 5 TA indicator(s) are bullish while SDZXF’s TA Score has 3 bullish TA indicator(s).

  • BNXTF’s TA Score: 5 bullish, 4 bearish.
  • SDZXF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, SDZXF is a better buy in the short-term than BNXTF.

Price Growth

BNXTF (@Pharmaceuticals: Generic) experienced а -12.53% price change this week, while SDZXF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.80%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +86.08%.

Reported Earning Dates

SDZXF is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.80% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SDZXF($26.2B) has a higher market cap than BNXTF($80.6M). BNXTF YTD gains are higher at: 167.050 vs. SDZXF (50.916). SDZXF has higher annual earnings (EBITDA): 1.05B vs. BNXTF (-5.38M). SDZXF has more cash in the bank: 1.39B vs. BNXTF (80.1K). BNXTF has less debt than SDZXF: BNXTF (5.61M) vs SDZXF (5.69B). SDZXF has higher revenues than BNXTF: SDZXF (10.6B) vs BNXTF (42K).
BNXTFSDZXFBNXTF / SDZXF
Capitalization80.6M26.2B0%
EBITDA-5.38M1.05B-1%
Gain YTD167.05050.916328%
P/E RatioN/A119.54-
Revenue42K10.6B0%
Total Cash80.1K1.39B0%
Total Debt5.61M5.69B0%
TECHNICAL ANALYSIS
Technical Analysis
BNXTFSDZXF
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
29%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 2 days ago
30%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend about 1 month ago
66%
N/A
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 2 days ago
27%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 2 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SDZXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
UFT.X0.003510-0.000001
-0.03%
UniLend cryptocurrency
ARK.X0.426707-0.006849
-1.58%
Ark cryptocurrency
CLV.X0.019915-0.000445
-2.19%
CLV cryptocurrency
TAO.X314.605320-9.678375
-2.98%
Bittensor cryptocurrency
CKB.X0.004718-0.000158
-3.24%
Nervos Network cryptocurrency

BNXTF and

Correlation & Price change

A.I.dvisor tells us that BNXTF and TAK have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNXTF and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNXTF
1D Price
Change %
BNXTF100%
+2.55%
TAK - BNXTF
32%
Poorly correlated
+0.72%
SNOA - BNXTF
29%
Poorly correlated
+4.42%
SDZXF - BNXTF
29%
Poorly correlated
N/A
ALVO - BNXTF
13%
Poorly correlated
+3.61%
ESAIY - BNXTF
11%
Poorly correlated
+2.66%
More

SDZXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SDZXF has been loosely correlated with SDZNY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SDZXF jumps, then SDZNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SDZXF
1D Price
Change %
SDZXF100%
N/A
SDZNY - SDZXF
44%
Loosely correlated
-1.30%
BNXTF - SDZXF
29%
Poorly correlated
-8.71%
AGYTF - SDZXF
20%
Poorly correlated
N/A
CBSTF - SDZXF
6%
Poorly correlated
-3.23%
ESAIY - SDZXF
5%
Poorly correlated
+3.05%
More